Homocysteine induces tau hyperphosphorylation in rats

Neuroreport. 2007 Dec 3;18(18):2005-8. doi: 10.1097/WNR.0b013e3282f29100.

Abstract

Epidemiological and clinical data suggest that homocysteine (Hcy) may increase the risk of Alzheimer's disease, but the underlying mechanisms are elusive. To investigate the effect of Hcy on phosphorylation of tau, we injected Hcy into the lateral cerebral ventricle of rats. We found that level of the hyperphosphorylated tau at PHF-1 (Ser396/404) and tau-1 (Ser198/199/202) epitopes was elevated prominently at 6, 9, and 12 h after the injection, and it was recovered to normal at 24 h. Simultaneously, the level of protein phosphatase-2A catalytic subunit (PP-2Ac) was reduced markedly as compared with control. These results imply that Hcy may induce hyperphosphorylation of tau with PP-2Ac involved mechanism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / metabolism
  • Alzheimer Disease / physiopathology
  • Animals
  • Binding Sites / drug effects
  • Binding Sites / physiology
  • Brain / drug effects
  • Brain / metabolism*
  • Brain / physiopathology
  • Brain Chemistry / drug effects
  • Brain Chemistry / physiology*
  • Homocysteine / metabolism*
  • Homocysteine / pharmacology
  • Hyperhomocysteinemia / complications
  • Hyperhomocysteinemia / metabolism
  • Hyperhomocysteinemia / physiopathology
  • Injections, Intraventricular
  • Male
  • Neurofibrillary Tangles / drug effects
  • Neurofibrillary Tangles / metabolism*
  • Phosphorylation / drug effects
  • Protein Phosphatase 2 / drug effects
  • Protein Phosphatase 2 / metabolism
  • Rats
  • Rats, Wistar
  • Serine / metabolism
  • Time Factors
  • tau Proteins / chemistry
  • tau Proteins / drug effects
  • tau Proteins / metabolism*

Substances

  • tau Proteins
  • Homocysteine
  • Serine
  • Ppp2ca protein, rat
  • Protein Phosphatase 2